Denosumab-desu
Generic Name: denosumab-desu
Manufactured by ACCORD BIOPHARMA INC.. Dosage form: INJECTABLE. Route: SUBCUTANEOUS. Active ingredients: denosumab-desu (120MG/1.7ML). Application: BLA761424.
Overview
Manufactured by ACCORD BIOPHARMA INC.. Dosage form: INJECTABLE. Route: SUBCUTANEOUS. Active ingredients: denosumab-desu (120MG/1.7ML). Application: BLA761424.
Dosage
Available as injectable for subcutaneous use.
Related Medications
Hazelnut Filbert Corylus Spp.
hazelnut filbert corylus spp.
Dosage form: INJECTION, SOLUTION. Route: PERCUTANEOUS, SUBCUTANEOUS. Active ingredients: HAZELNUT, UNSPECIFIED (.1 g/mL). Category: BLA.
Niobium Metallicum
niobium metallicum
Lamivudine And Zidovudine
lamivudine and zidovudine
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
11 DESCRIPTION Lamivudine and Zidovudine tablets, USP are combination tablets containing lamivudine and zidovudine. Lamivudine (EPIVIR) and zidovudine (RETROVIR, azidothymidine, AZT, or ZDV) are synthetic nucleoside analogues with activity against HIV-1. Lamivudine and Zidovudine tablets, USP are for oral administration.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.